| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.45 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |